San Antonio, TX, United States of America

Kevin Hughes

This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Signal Pharmaceuticals, Inc., Pharmacopeia Drug Discovery, Inc.. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Hughes. Retrieved from https://idiyas.com/inventor/kevin-hughes-u075p8h8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 17.9

ph-index = 3

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kevin Hughes: Innovator in Aminopurine Compounds

Introduction

Kevin Hughes is a notable inventor based in San Antonio, Texas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminopurine compounds. With a total of three patents to his name, Hughes has established himself as a key figure in innovative drug discovery.

Latest Patents

Hughes' latest patents include "Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith." These patents provide detailed descriptions of aminopurine compounds that have the potential to impact various therapeutic applications. His work focuses on the structural properties of these compounds and their implications for treatment methodologies.

Career Highlights

Throughout his career, Kevin Hughes has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Signal Pharmaceuticals, Inc. and Pharmacopeia Drug Discovery, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Hughes has collaborated with several professionals in his field, including Ronald J. Albers and Leticia Ayala. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Kevin Hughes is a distinguished inventor whose work in aminopurine compounds has the potential to advance pharmaceutical treatments. His contributions to the industry are marked by his innovative patents and collaborations with other professionals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…